LysoPE(16:0/0:0)
|
Basic information |
| Metabolite name | LysoPE(16:0/0:0) |
 | HMDB0011503 |
 |
N/A |
 |
9547069 |
| Synonyms | 1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine |
| No. of studies | 7 |
|
Basic information |
| Metabolite name | LysoPE(16:0/0:0) |
| HMDB0011503 |
|
N/A |
|
9547069 |
| Synonyms | 1-Palmitoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine |
| No. of studies | 7 |
|
Relationship between LysoPE(16:0/0:0) and depression (count: 7) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M1039 | Type1 | CUMS group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M1072 | Type1 | CUMS group vs. control group | Faece | Cynomolgus monkey | Down |
| Study M460 | Type1 | depressed group vs. control group | Liver | Kunming mouse | Up |
| Study M555 | Type1 | FMT group vs. control group | Liver | Sprague-Dawley rat | Up |
| Study M578 | Type1 | restraint stress offspring group vs. control offspring group | Hippocampus | Sprague-Dawley rat | Down |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Faece | BALB/c mouse | Up |
| Study M846 | Type2 | postpartum depression model + 919 syrup group vs. postpartum depression model group | Hippocampus | BALB/c mouse | Down |